Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B I Rini
First-, Second-, Third-Line Therapy for mRCC: Benchmarks for Trial Design From the IMDC
British Journal of Cancer
Cancer Research
Oncology
Related publications
Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial
Clinical Genitourinary Cancer
Oncology
Urology
Vinorelbine and Gemcitabine as Second- Or Third-Line Therapy for Malignant Pleural Mesothelioma
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Benchmarks for Antiretroviral Therapy
Journal of Clinical Investigation
Medicine
Capecitabine and Oxaliplatin in Combination as First- Or Second-Line Therapy for Metastatic Breast Cancer: A Wisconsin Oncology Network Trial
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Treatment Paradigms for Patients With Metastatic Non-Small-Cell Lung Cancer: First-, Second-, and Third-Line
Current Oncology
Oncology
Establishment of a First‑line Second‑line Treatment Model for Human Pulmonary Adenocarcinoma
Oncology Letters
Cancer Research
Oncology
Extracorporeal Photochemotherapy as Second- Or First-Line Therapy of Acute GVHD?
Bone Marrow Transplantation
Transplantation
Hematology
Safety and Continuity of Second- And Third-Line Therapy With Paclitaxel or Irinotecan for Advanced and Recurrent Gastric Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Third- Or Later-Line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice
Clinical Colorectal Cancer
Oncology
Gastroenterology